Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 292
Filter
1.
Arq. gastroenterol ; Arq. gastroenterol;56(1): 45-50, Jan.-Mar. 2019. tab, graf
Article in English | LILACS | ID: biblio-1001332

ABSTRACT

ABSTRACT BACKGROUND: Hepatocellular carcinoma (HCC) can be the last step of non-alcoholic fatty liver disease (NAFLD) evolution. Experimental models are crucial to elucidate the pathogenesis of HCC secondary to NAFLD. The 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) plays an important role in evaluating HCC development and progression. OBJECTIVE: To standardize the imaging method of PET/CT with 18F-FDG as an evaluation tool of the experimental model of HCC secondary to NAFLD. METHODS: Ten male Sprague-Dawley rats were fed with choline-deficient high-fat diet and diethylnitrosamine (DEN) in the drinking water for 16 weeks and then received 1 mL of saline solution (0.9%) daily by gavage for three weeks. At the 16th and 19th weeks, abdominal ultrasonography (USG) was performed. 18F-FDG PET/CT images were obtained before the beginning of experiment (week 0) and at the end (week 19). Histological and immunohistochemically analysis were also performed. RESULTS: The USG results showed a homogeneous group at the 16th week with an average of 4.6±2.74 nodules per animal. At the 19th week, PET/CT findings demonstrated an average of 8.5±3.7 nodules per animal. The mean values of SUVmed and SUVmax were 2.186±0.1698 and 3.8±1.74, respectively. The average number of nodules per animal in the histological analysis was 5.5±1.5. From all nodules, 4.6% were classified as well-differentiated HCC and 81.8% were classified as poorly-differentiated HCC. CONCLUSION: 18F-FDG PET/CT was able to evaluate the development of HCC in an experimental model of NAFLD non-invasively. From the standardization of PET/CT in this model, it is possible to use this tool in future studies to monitor, in vivo and non-invasively, the progression of HCC.


RESUMO BACKGROUND: O carcinoma hepatocelular (CHC) pode ser a última fase da doença hepática gordurosa não alcoólica (DHGNA). Modelos experimentais são cruciais para elucidação da patogênese do CHC secundário a DHGNA. A tomografia por emissão de pósitrons/tomografia computadorizada (PET/TC) com 2-desoxi-2-(18F)fluoro-D-glicose (18F-FDG) desempenha um importante papel na avaliação do desenvolvimento e progressão do CHC. OBJETIVO: Padronizar a metodologia de imagem por PET/TC com 18F-FDG como uma ferramenta de avaliação do modelo experimental de CHC secundário a DHGNA. MÉTODOS: Dez ratos Sprague-Dawley machos foram alimentados com dieta hiperlipídica deficiente em colina associada a dietilnitrosamina (DEN) na água de beber por 16 semanas e depois receberam 1 mL de solução salina (0,9%) por gavagem diariamente por três semanas. Nas 16ª e 19ª semanas, foi realizada a ultrassonografia abdominal. As imagens do PET/TC com 18F-FDG foram obtidas antes do início do experimento (semana 0) e no final (semana 19). Análises histológica e imunohistoquímica também foram realizadas. RESULTADOS: Os resultados da ultrassonografia demonstraram um grupo homogêneo na 16ª semana com uma média de 4,6±2,74 nódulos por animal. Na 19ª semana, os achados do PET/CT demonstraram uma média de 8,5±3,7 nódulos por animal. Os valores médios de SUVmed e SUVmáx foram 2,186±0,1698 e 3,8±1,74, respectivamente. A média do número de nódulos na análise histológica foi de 5,5±1,5. De todos os nódulos, 4,6% foram classificados como bem diferenciados e 81,8% foram classificados como CHC pouco diferenciado. CONCLUSÃO: O PET/TC com 18F-FDG foi capaz de avaliar o desenvolvimento do CHC secundário a DHGNA de forma não invasiva. A partir da padronização do PET/CT neste modelo, faz-se possível a utilização desta ferramenta em futuros estudos para monitorar, in vivo e de forma não invasiva, a progressão do CHC.


Subject(s)
Animals , Male , Carcinoma/diagnostic imaging , Positron Emission Tomography Computed Tomography/methods , Liver Neoplasms, Experimental/diagnostic imaging , Prognosis , Carcinoma/pathology , Carcinoma/secondary , Ultrasonography , Rats, Sprague-Dawley , Radiopharmaceuticals/administration & dosage , Fluorodeoxyglucose F18/administration & dosage , Disease Models, Animal , Neoplasm Grading , Non-alcoholic Fatty Liver Disease/complications , Positron Emission Tomography Computed Tomography/standards , Liver Neoplasms, Experimental/pathology , Liver Neoplasms, Experimental/secondary , Neoplasm Staging
2.
Article in English | WPRIM | ID: wpr-741442

ABSTRACT

OBJECTIVE: To evaluate the impact of energy and access methods on extrahepatic tumor spreading and the ablation zone in an ex vivo subcapsular tumor mimic model with a risk of extrahepatic tumor spreading. MATERIALS AND METHODS: Forty-two tumor-mimics were created in bovine liver blocks by injecting a mixture of iodine contrast material just below the liver capsule. Radiofrequency (RF) ablations were performed using an electrode placed parallel or perpendicular to hepatic surface through the tumor mimic with low- and high-power protocols (groups 1 and 2, respectively). Computed tomography (CT) scans were performed before and after ablation. The presence of contrast leak on the hepatic surface on CT, size of ablation zone, and timing of the first roll-off and popping sound were compared between the groups. RESULTS: With parallel access, one contrast leak in group 1 (1/10, 10%) and nine in group 2 (9/10, 90%) (p < 0.001) were identified on post-ablation CT. With perpendicular access, six contrast leaks were identified in each group (6/11, 54.5%). The first roll-off and popping sound were significantly delayed in group 1 irrespective of the access method (p = 0.002). No statistical difference in the size of the ablation zone of the liver specimen was observed between the two groups (p = 0.247). CONCLUSION: Low-power RF ablation with parallel access is proposed to be effective and safe from extrahepatic tumor spreading in RF ablation of a solid hepatic tumor in the subcapsular location. Perpendicular placement of an electrode to the capsule is associated with a risk of extrahepatic tumor spreading regardless of the power applied.


Subject(s)
Animals , Catheter Ablation , Electrodes , Iodine , Liver , Liver Neoplasms, Experimental , Methods , Neoplasm Seeding
3.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;51(3): e6650, 2018. graf
Article in English | LILACS | ID: biblio-889040

ABSTRACT

In the present study, we successfully developed a docetaxel (DTX) and thalidomide (TDD) co-delivery system based on low density lipoprotein (LDL) modified silica nanoparticles (LDL/SLN/DTX/TDD). By employing the tumor homing property of LDL and the drug-loading capability of silica nanoparticles, the prepared LDL/SLN/DTX/TDD was expected to locate and specifically deliver the loaded drugs (DTX and TDD) to achieve effective chemotherapy of liver cancer. In vitro analysis revealed that nano-sized LDL/SLN/DTX/TDD with decent drug loading capabilities was able to increase the delivery efficiency by targeting the low density lipoprotein receptors, which were overexpressed on HepG2 human hepatocellular liver carcinoma cell line, which exerted better cytotoxicity than unmodified silica nanoparticles and free drugs. In vivo imaging and anti-cancer assays also confirmed the preferable tumor-homing and synergetic anti-cancer effects of LDL/SLN/DTX/TDD.


Subject(s)
Humans , Animals , Male , Mice , Thalidomide/administration & dosage , Silicon Dioxide/administration & dosage , Taxoids/administration & dosage , Lipoproteins, LDL/blood , Liver Neoplasms, Experimental/drug therapy , Antineoplastic Agents/administration & dosage , Thalidomide/therapeutic use , Time Factors , Taxoids/therapeutic use , Drug Synergism , Nanoparticles , Hep G2 Cells , Liver Neoplasms, Experimental/blood , Antineoplastic Agents/therapeutic use
4.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;51(4): e6867, 2018. graf
Article in English | LILACS | ID: biblio-889068

ABSTRACT

Polydatin, a small molecule from Polygonum cuspidatum, has many biological functions, particularly anti-cancer effects. However, the anti-cancer effects of polydatin in hepatocellular carcinoma (HCC) have not been examined yet. In the present study, MTT assay, BrdU assay, transwell invasion assay, and wound healing assay were performed to determine cell proliferation, invasion and migration. Flow cytometry and TUNEL assay were used to measure cell apoptosis. Quantitative real-time PCR and western blotting assays were used to determine mRNA and protein expression levels. Xenograft experiment was performed to determine the in vivo anti-tumor effect of polydatin. Immunostaining was performed to analyze the expression of caspase-3 and Ki-67. Our results showed that polydatin inhibited cell proliferation in a concentration-dependent and time-dependent manner in the HCC cell lines. Polydatin also induced cell apoptosis in a concentration-dependent manner possibly via increasing the caspase-3 activity, and up-regulating the protein expression of caspase-3, caspase-9, Bax, and down-regulating the protein expression of Bcl-2. In addition, polydatin treatment had an inhibitory effect on cell proliferation, invasion and migration in HCC cell lines. Polydatin treatment also suppressed the Wnt/beta-catenin signaling activities in HCC cells. Polydatin treatment significantly reduced tumor growth in nude mice inoculated with HepG2 cells, suppressed the expression of Ki-67, and increased caspase-3 expression and TUNEL activity. Our data indicated the important role of polydatin for the suppression of HCC progression.


Subject(s)
Animals , Male , Mice , Stilbenes/pharmacology , Cell Movement/drug effects , Apoptosis/drug effects , Carcinoma, Hepatocellular/drug therapy , Cell Proliferation/drug effects , Glucosides/pharmacology , Liver Neoplasms, Experimental/drug therapy , Drugs, Chinese Herbal , Blotting, Western , Carcinoma, Hepatocellular/pathology , Cell Line, Tumor , Real-Time Polymerase Chain Reaction , Flow Cytometry , Liver Neoplasms, Experimental/pathology , Mice, Inbred BALB C , Mice, Nude , Neoplasm Invasiveness
5.
Article in English | WPRIM | ID: wpr-301045

ABSTRACT

<p><b>OBJECTIVE</b>To study whether the ethanol extract of Phellinus merrillii (EPM) has chemopreventive potential against liver carcinogenesis.</p><p><b>METHODS</b>Thirty male Spraque-Dawley rats were randomly divided into control group, EPM control group, hepatocarcinoma control group, low-dose EPM group and high-dose EPM group, 6 in each group. Using the Solt and Farber protocol in a rat model of hepatocarcinogenesis, the chemopreventive effect of EPM on diethylnitrosamine (DEN)-initiated, 2-acetylaminofluorene (2-AAF) and partial hepatectomy (PH)-promoted liver carcinogenesis in rats was evaluated. Basic pathophysiological and histological examinations, together with the serum levels of glutamic oxaloacetic transaminase (sGOT), glutamic pyruvic transaminase (sGPT) and gamma-glutamyl transpeptidase (γ-GT) were measured.</p><p><b>RESULTS</b>Treatment of EPM at the concentration of 2 g/kg body weight in the diet for 8 weeks clearly prevented the development of carcinogenesis and reduced the levels of sGOT, sGPT, and serum γ-GT of rats as compared with the hepatocarcinoma control group (P<0.05 or P<0.01). These phenotypes were accompanied by a significant increase in natural killer cell activity.</p><p><b>CONCLUSION</b>EPM showed a strong liver preventive effect against DEN+2-AAF+PH-induced hepatocarcinogenesis in a rat model.</p>


Subject(s)
Animals , Male , Rats , 2-Acetylaminofluorene , Basidiomycota , Chemistry , Carcinogenesis , Cytoprotection , Diethylnitrosamine , Ethanol , Chemistry , Liver Neoplasms, Experimental , Plant Extracts , Chemistry , Pharmacology , Protective Agents , Pharmacology , Rats, Sprague-Dawley
6.
Acta cir. bras ; Acta cir. bras;31(11): 724-729, Nov. 2016. graf
Article in English | LILACS | ID: biblio-827660

ABSTRACT

ABSTRACT PURPOSE: To investigate the hepatotoxicity and nephrotoxicity of 3-Bromopyruvate (3BP) in mice. METHODS: Fifteen nude mice were grafted subcutaneously in the left flank with MDA-MB-231 cells, then all mice were divided into control group (PBS), 3BP group (8 mg/kg), positive group (DNR: 0.8 mg/kg) when tumor volume reached approximately 100 mm3. 28 days later, tumors, livers and kidneys were stored in 4 % formalin solution and stained with hematoxylin and eosin staining. The Kunming mice experiment included control group (PBS), 3BP group (4mg/kg; 8mg/kg; 16mg/kg), positive group (DNR: 0.8 mg/kg). 24 hours later, the blood were used for the determination of hepatic damage serum biomarkers. Livers were stored in 4 % formalin solution for the later detection. RESULTS: 3BP at the dose of 8mg/kg had a good effect on inhibiting tumor growth in nude mice and did not damage liver and kidney tissues. Kunming mice experiment showed 3BP at the dose of 16mg/kg did damage to liver tissues. CONCLUSION: 3-Bromopyruvate at the dose of suppressing tumor growth did not exhibit hepatotoxicity and nephrotoxicity in nude mice, and the effect on liver was confirmed in Kunming mice.


Subject(s)
Animals , Female , Mice , Pyruvates/toxicity , Enzyme Inhibitors/toxicity , Chemical and Drug Induced Liver Injury/pathology , Acute Kidney Injury/pathology , Kidney/drug effects , Liver/drug effects , Disease Models, Animal , Dose-Response Relationship, Drug , Acute Kidney Injury/chemically induced , Liver Neoplasms, Experimental/drug therapy , Mice, Inbred BALB C , Mice, Nude
7.
Article in Chinese | WPRIM | ID: wpr-255154

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the anticancer efficacy and the hepatic and renal toxicity of As2O3-lipiodol emulsion via transarterial embolization in a rabbit VX2 liver tumor model.</p><p><b>METHODS</b>VX2 tumors were implanted in rabbit livers successfully, followed by transarterial embolization with high-dose As2O3(5 mg/kg with 0.2 mL lipiodol, n=10), low-dose As2O3(1 mg/kg with 0.2 mL lipiodol, n=10), and control(0.2 mL lipiodol, n=10). The growth ratios and microvessel densities(MVDs) of the tumors were estimated by multi-row spiral CT and CD34 immunohistochemical staining, respectively. Hepatic and renal function was also evaluated by means of blood biochemical analysis.</p><p><b>RESULTS</b>The growth ratios of the tumors differed significantly among three groups(P<0.01). The high-dose and low dose group showed significantly lower tumor growth ratios[44.05%(-36.40%~64.60%), 95.20%(-11.60%~159.40%)] than control group[145.55%(98.90%~250.30%), all P<0.05]. The MVDs of the tumors were significantly lower in the high-dose(21.4±10.6) and low-dose group(34.1±12.0) than those in control group(57.9±16.1,all P<0.05). The levels of blood ALT and AST obtained 28 days after transarterial embolization were significantly lower in the high-dose[(25.50±12.37)U/L,(24.25±10.89)U/L] and low-dose group[(45.00±14.04)U/L,(35.22±11.86)U/L] than in control group[(79.12±30.52)U/L,(75.25±25.89)U/L, all P<0.05].</p><p><b>CONCLUSION</b>As2O3-lipiodol emulsion via transarterial embolization has anticancer effect without significant hepatic and renal functional damage in rabbit VX2 liver tumors.</p>


Subject(s)
Animals , Rabbits , Antineoplastic Agents , Pharmacology , Arsenicals , Pharmacology , Embolization, Therapeutic , Emulsions , Pharmacology , Ethiodized Oil , Pharmacology , Liver Neoplasms, Experimental , Drug Therapy , Oxides , Pharmacology , Tomography, Spiral Computed
8.
Hist. ciênc. saúde-Manguinhos ; Hist. ciênc. saúde-Manguinhos;21(4): 1131-1149, Oct-Dec/2014.
Article in Portuguese | LILACS | ID: lil-732507

ABSTRACT

Associadas a projetos de construção da ideia de nação, no Brasil monárquico foram encaminhadas, pelo governo imperial, algumas iniciativas no sentido de materializar propostas de educação física. O objetivo deste artigo é investigar os sentidos e significados atribuídos ao tema na legislação e nos relatórios anuais do Ministério dos Negócios do Império (1831-1889), com especial interesse pelo que se refere ao Rio de Janeiro. A abordagem do assunto nas fontes pesquisadas evidencia que as visões sobre a educação física se deram a partir de uma matriz que articulava concepções de moral, saúde e civilização, tendo que lidar com as condições concretas de um país recém-independente, periférico e com uma burocracia ainda em formação.


In association with its nation building projects, the imperial government in Brazil under monarchic rule took some concrete actions based on proposals for physical education. The aim of this article is to investigate the meanings and significations attributed to this subject in the legislation and the annual reports issued by the Ministry of Business of the Empire (1831-1889), giving special attention to Rio de Janeiro. The approach to the subject in the sources researched demonstrates that the views of physical education took shape through a web of ideas that associated moral, health and civilization conceptions, in a bid to deal with the concrete circumstances of a newly independent peripheral nation with a bureaucratic structure in the process of formation.


Subject(s)
Animals , Female , Mice , Carcinoma, Lewis Lung/secondary , Cathepsin B/antagonists & inhibitors , Cathepsins/antagonists & inhibitors , Endopeptidases , Leucine/analogs & derivatives , Liver Neoplasms, Experimental/prevention & control , Liver Neoplasms, Experimental/secondary , Neoplasm Invasiveness/prevention & control , Cathepsin L , Collagen , Cysteine Endopeptidases , Carcinoma, Lewis Lung/metabolism , Drug Combinations , Drug Screening Assays, Antitumor , Laminin , Leucine/pharmacokinetics , Leucine/pharmacology , Liver Neoplasms, Experimental/enzymology , Proteoglycans , Tumor Cells, Cultured
9.
Rev. panam. salud pública ; 36(5): 336-341, nov. 2014. graf, tab
Article in Spanish | LILACS | ID: lil-733237

ABSTRACT

La epidemia de chikungunya en la República Dominicana se inició en febrero de 2014. En los primeros seis meses se registraron 429 421 casos, que representaron 65% de todos los notificados a la Organización Panamericana de la Salud por 33 países y territorios de la Región de las Américas. Esta epidemia se ha transmitido con rapidez en dicho país y ha demandado una intensa respuesta intersectorial, que ha liderado el Ministerio de Salud Pública y, especialmente, el Sistema Nacional de Vigilancia Epidemiológica y la red de los servicios de salud. Considerando que afectará a miles de personas, el objetivo de este artículo es describir las actuaciones realizadas y compartir los resultados y las lecciones aprendidas durante estos primeros meses con los ministerios de salud y los profesionales de los países de la Región para ayudarles a preparar una respuesta adecuada para afrontarla de forma efectiva y eficiente.


The chikungunya epidemic in the Dominican Republic began in February 2014. During the first six months 429 421 cases were recorded, representing 65% of all those notified to the Pan American Health Organization by 33 countries and territories of the Region of the Americas. This epidemic has spread quickly in the Dominican Republic, requiring a focused intersectoral response, led by the Ministry of Public Health and involving major efforts by the National Epidemiological System and the health services network. Given that the virus will affect thousands of people, this article seeks to describe the actions that have already been carried out, and to share the results and lessons learned during these first months with health ministries and professionals in the countries of the Region, in order to assist them to prepare an appropriate response to confront the epidemic effectively and efficiently.


Subject(s)
Animals , Rats , Cell Nucleus/metabolism , Cytoplasm/metabolism , HSP90 Heat-Shock Proteins/metabolism , Receptors, Glucocorticoid/metabolism , Cell Line , Dexamethasone/pharmacology , Haplorhini , Kidney , Liver Neoplasms, Experimental , Molybdenum/pharmacology , Receptors, Glucocorticoid/genetics , Transfection , Tumor Cells, Cultured
10.
Indian J Exp Biol ; 2014 Oct; 52(10): 943-951
Article in English | IMSEAR | ID: sea-153783

ABSTRACT

The anti proliferative potential of siRNA26, targeted to Aurora kinase B, in prostate cancer cells is known from a previous study from our laboratory. Here we first show that siRNA26 cleaves at the same position of the target mRNA in the prostate cancer and hepatocellular carcinoma cell lines, PC3 and HepG2 respectively. Aurorakinase B specific siRNA, but not a control siRNA, inhibited PC3 and HepG2 cell proliferation and cell migration. These effects correlated to RNA silencing of Aurorakinase B in both the cell lines. Intra-tumoral administration of HiPerfect complexed siRNA26 inhibited the growth of HepG2 xenografts in SCID mice. In an orthotopic setting, intravenous administration of HiPerfect encapsulated siRNA26 appeared to reduce the severity of multifocal lesions.


Subject(s)
Animals , Antineoplastic Agents/pharmacology , Aurora Kinase B/genetics , Aurora Kinase B/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , Female , Hep G2 Cells , Humans , Liver Neoplasms, Experimental/genetics , Liver Neoplasms, Experimental/metabolism , Liver Neoplasms, Experimental/therapy , Male , Mice , Mice, SCID , Prostatic Neoplasms/genetics , Prostatic Neoplasms/metabolism , Prostatic Neoplasms/therapy , RNA Interference , RNA, Messenger/chemistry , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , RNA, Small Interfering/pharmacology , Transfection , Xenograft Model Antitumor Assays
11.
Acta Pharmaceutica Sinica ; (12): 44-49, 2014.
Article in Chinese | WPRIM | ID: wpr-297973

ABSTRACT

This study is to investigate the anti-tumor activities of a novel cyclophosphamide derivate 4, 6-diphenyl cyclophosphamide (9b) in vivo and in vitro, and its possible mechanism of action. The inhibitory effects of 9b on human hepatoma cell line HepG2, human breast carcinoma cell line MCF-7 and human myeloid leukemia cell line K562 were measured by MTT assay in vitro. Cell cycle distribution and apoptotic rate were evaluated by flow cytometry. To evaluate the anti-tumor effect of 9b in vivo, mouse model bearing inoculated H22 tumor was established. The results indicated that 9b could inhibit the proliferation of HepG2, MCF-7 and K562 cells in a dose and time dependent manner. The ICo50 values of 9b were 32.34 micromol.L-1 to HepG2 cells, 87.07 micromol.L-1 to MCF-7 cells and 149.10 micromol.L-1 to K562 cells after incubation for 48 h. The results of flow cytometry indicated that after being treated for 48 h with different concentrations of 9b, the ratios of HepG2, MCF-7 cells at the Go/G1 phase and K562 cells at the G0/Gl phase and G2/M phase increased significantly compared with control group, and the apoptotic rate increased with the increase of the concentration of 9b. 9b could significantly reduce tumor weight of H22 solid tumor mouse model in vivo. To summarize, 9b showed significantly anti-tumor activity in vivo and in vitro, of which the mechanism might be associated with the change of cell cycle distribution and induction of tumor cell apoptosis.


Subject(s)
Animals , Female , Humans , Male , Mice , Antineoplastic Agents, Alkylating , Chemistry , Pharmacology , Apoptosis , Cell Cycle , Cell Line, Tumor , Cell Proliferation , Cyclophosphamide , Chemistry , Pharmacology , Dose-Response Relationship, Drug , Inhibitory Concentration 50 , Liver Neoplasms, Experimental , Pathology , Molecular Structure , Random Allocation , Tumor Burden
12.
Article in English | WPRIM | ID: wpr-819674

ABSTRACT

OBJECTIVE@#To investigate the inhibitory effect of humanized anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles conjugate on growth of human hepatocellular carcinoma both in vitro and in vivo, which may be a potential agents with sensitivity and targeting ability for human hepatocellular cancer.@*METHODS@#Humanized anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles conjugate was previously constructed using ribosome display technology and antibody conjugate technology. In this combined in vitro and in vivo study, the inhibitory effects of anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles conjugate on tumor growth, invasion, and metastasis was observed with human liver carcinoma cell line Bel7402 and normal cell L02 by MTT assay, Tanswell assay, Hochest33258 staining, and DNA ladder analysis. The anticancer activity and distribution of anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles was then verified in a mouse model of Bel7402 xenografts.@*RESULTS@#Anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles significantly inhibited the proliferation of Bel7402 in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay while had almost no effects on L02 cells. And the apoptosis inducing effects were proved by Hochest33258 staining and DNA ladder analysis. Transwell assay found that the drug also inhibited the metastasis ability of tumor cells. Furthermore, anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles significantly delayed the growth of Bel7402 xenografts after administration (92.9%), followed by As2O3-stealth nanoparticles, anti-VEGFR-2 ScFv, and As2O3 (61.4%, 58.8%, 20.5%, P<0.05). The concentration of As2O3 in anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles group was more selectively.@*CONCLUSIONS@#Anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles is a potent and selective anti-hepatocellular carcinoma agent which could inhibit the growth of liver cancer as a targeting agent both in vitro and in vivo and also significantly inhibit angiogenesis.


Subject(s)
Animals , Humans , Mice , Antineoplastic Agents , Chemistry , Pharmacokinetics , Pharmacology , Apoptosis , Arsenic Trioxide , Arsenicals , Chemistry , Pharmacokinetics , Pharmacology , Cell Line, Tumor , Cell Movement , Cell Proliferation , Drug Delivery Systems , Liver Neoplasms , Liver Neoplasms, Experimental , Microvessels , Nanoparticles , Chemistry , Metabolism , Neovascularization, Pathologic , Pathology , Oxides , Chemistry , Pharmacokinetics , Pharmacology , Single-Chain Antibodies , Chemistry , Metabolism , Vascular Endothelial Growth Factor Receptor-2 , Metabolism
13.
Article in Chinese | WPRIM | ID: wpr-249422

ABSTRACT

<p><b>OBJECTIVE</b>To establish a modified rat model of liver cancer with concurrent cirrhosis for the study of carcinogenesis characteristics and drug intervention of liver cancer.</p><p><b>METHODS</b>Fifty male Wistar rats weighing 100-120 g were randomly divided into normal control group (20 rats) and model group (30 rats). In the model group, the rats were subjected to intraperitoneal injection of 50 mg/kg DEN N-diethylnitrosamine (DEN) twice a week for 4 consecutive weeks, followed then by weekly injections for another 10 weeks. The control rats received injections of 0.1 ml saline in the same manner. At 2, 4, 8, 12, 14, and 18 weeks, 3 rats from each group were sacrificed for assessing tumor formation and liver cirrhosis.</p><p><b>RESULTS</b>Liver cancer with concurrent cirrhosis was induced successfully after 14 weeks of DEN injections. At the 14th week, 3 out of the 5 rats were found to have cirrhosis and LC, and at the 18th week, all the 3 rats examined had cirrhosis and liver cancer. The total carcinogenesis rate in the rats was 75% at 18 weeks with an overall mortality of 33%.</p><p><b>CONCLUSION</b>This approach to establishing rat models of liver cancer with concurrent cirrhosis requires simple operation, shortens the time of carcinogenesis, and ensures a high success rate of carcinogenesis and a low mortality rate. The carcinogenesis characteristics in this model are similar to those in human.</p>


Subject(s)
Animals , Male , Rats , Liver Cirrhosis, Experimental , Pathology , Liver Neoplasms, Experimental , Pathology , Rats, Wistar
14.
Article in English | WPRIM | ID: wpr-351028

ABSTRACT

Tumors are believed to consist of a heterogeneous population of tumor cells originating from rare cancer stem cells (CSCs). However, emerging evidence suggests that tumor may also originate from non-CSCs. To support this viewpoint, we are here to present definitive evidence indicating that the number of tumorigenic tumor cells is greater than that of CSCs in tumor, and tumor can also derive from non-CSCs. To achieve this, an idealized mathematical model was employed in the present study and theoretical calculation revealed that non-CSCs could initiate the occurrence of tumor if their proliferation potential was adequate. Further, experimental studies demonstrated that 17.7%, 38.6% and 5.2% of tumor cells in murine B16 solid melanoma, H22 hepatoma and Lewis lung carcinoma, respectively, were potentially tumorigenic. Thus, based on the aforementioned findings, we propose that the scarce CSCs, if exist, are not the sole source of a tumor.


Subject(s)
Animals , Algorithms , Carcinogenesis , Pathology , Carcinoma, Lewis Lung , Pathology , Cell Differentiation , Cell Line, Tumor , Cell Proliferation , Liver Neoplasms, Experimental , Pathology , Melanoma, Experimental , Pathology , Mice, Inbred BALB C , Mice, Inbred C57BL , Models, Biological , Neoplasms, Experimental , Pathology , Neoplastic Stem Cells , Pathology , Time Factors , Tumor Stem Cell Assay , Methods
15.
AJMB-Avicenna Journal of Medical Biotechnology. 2014; 6 (4): 200-209
in English | IMEMR | ID: emr-149833

ABSTRACT

Telomerase activity increases in cancer cells. Bcl-2 is an antiapoptotic factor that its concentration grows in many cancer cells including hepatocellular carcinoma cells. In this study, an attempt was made to investigate the effects of a new synthetic compound, platinum azidothymidine [Pt-AZT] on treatment of rats with Hepatocellular Carcinoma [HCC] and to compare its effects with azidothymidine [AZT] in alteration of telomerase activity and Bcl-2 concentration in HCC. Healthy adult male Wistar rats [n=100] were randomly divided into 4 groups [A, B, C, and D]. Group A contained 25 healthy rats and was considered as the control group. Liver preneoplastic lesions were induced in remaining animals [n=75] using Solt-Farber resistant hepatocyte protocol. These animals were randomly allocated in groups B, C and D. Group B was negative control [untreated], groups C and D were treated by intraperitoneal injection [IP] of Pt-AZT [0.9 mg/kg/day] and AZT [0.3 mg/kg/day], respectively for 14 days. After the treatment period, telomerase activity and Bcl-2 concentration were determined in the rats' liver. No HCC was developed in group A, but tumors were present in all other groups. Telomerase activity and Bcl-2 concentration were significantly lower in group C compared to groups B [0.159 +/- 0.06 vs. 0.577 +/- 0.116 IU/L, p<0.001, respectively and 0.931 +/- 0.388 vs. 3.94 +/- 0.74 ng/ml, p<0.001, respectively]. Similar results were observed in comparison with group D [0.331 +/- 0.06 vs. 0.577 +/- 0.116 IU/L, p<0.001, respectively and 0.931 +/- 0.388 vs. 2.94 +/- 0.594 ng/ml, respectively]. There was a significant negative correlation between telomerase activity and Bcl-2 concentration only in untreated cancer group [p=0.034]. In this study, higher anticancer activity of Pt-AZT in comparison to AZT was demonstrated. It effectively inhibits the growth of liver tumor in rats through extending apoptosis


Subject(s)
Animals, Laboratory , Platinum , Zidovudine , Telomerase , Genes, bcl-2 , Liver Neoplasms , Liver Neoplasms, Experimental , Rats, Wistar
16.
Article in Chinese | WPRIM | ID: wpr-359279

ABSTRACT

<p><b>OBJECTIVE</b>To explore the mechanism of Xiaoai Jiedu Recipe (XJR) for fighting against tumors by detecting tumor gene expression profiles of H22 tumor-bearing mice.</p><p><b>METHODS</b>H22 tumor-bearing mice were randomly divided into the normal control group, the low dose XJR group, the medium dose XJR group, the high dose XJR group, and the Cisplatin group. The differentially expressed genes of tumor tissues in H22 tumor-bearing mice were detected by using gene chip technique. The antitumor mechanism of XJR associated signaling pathways and gene expressions were found out by pathway analysis. The chemokine signaling pathways were analyzed.</p><p><b>RESULTS</b>XJP could significantly affect multiple signaling pathways associated with tumor growth, apoptosis, and immunity. XJP also could decrease expressions of CCL3 and CXCL2 in the chemokine signaling pathway.</p><p><b>CONCLUSION</b>XJP could inhibit the growth and invasion of tumor cells possibly by affecting expressions of some genes in the chemokine signaling pathway.</p>


Subject(s)
Animals , Mice , Cell Line, Tumor , Chemokine CCL3 , Metabolism , Chemokine CXCL2 , Metabolism , Drugs, Chinese Herbal , Pharmacology , Gene Expression Profiling , Liver Neoplasms, Experimental , Genetics , Metabolism , Mice, Inbred ICR , Signal Transduction
17.
Article in Chinese | WPRIM | ID: wpr-252624

ABSTRACT

<p><b>OBJECTIVE</b>To assess the application of gray-scale contrast-enhanced ultrasound (CEUS) and contrast-enhanced spiral computed tomography (CECT) in detection of residual tumor after high intensity focused ultrasound (HIFU) ablation with microbubbles on rabbit hepatic VX2 tumors.</p><p><b>METHODS</b>Forty rabbits with hepatic VX2 tumors were randomly divided into three groups before ablation. Group I (n=10) served as sham ablation controls, rabbits in group II (n=15) and group III (n=15) were ablated using HIFU under the manipulation of computer. A bolus of 0.2 ml SonoVue solution was injected via ear marginal vein of rabbits in group III before ablation. Tumors were examined with CEUS and CECT before and within 3h after HIFU ablation. Necropsy and histopathological assessment were performed immediately after the completion of images evaluation.</p><p><b>RESULTS</b>Before ablation, intense arterial feeding vessels was detected in the tumors (77.5%,31/40 Compared with 52.5%,21/40) or the periphery of the tumors (22.5%,9/40 Compared with 47.5%,19/40) by CEUS and CECT, respectively. The tumors were characterized by quick wash-in and wash-out (high and rapid peak of enhancement in the arterial phase,followed by a fast decrease in enhancement level). The dose parameters used to achieve therapeutic effect in group III were significantly lower than those in group II(P<0.01). There were local residual viable tumor tissues due to incomplete ablation in 60.0% (9/15) of group II and 13.3% (2/15) of group III revealed by histopathology(P<0.05). The concordance rate of CECT and CEUS with histopathology on residual tumor detection was 27.3% and 81.8% (P<0.05), respectively.</p><p><b>CONCLUSION</b>The administration of microbubble agent enhances the efficacy of HIFU on rabbit hepatic VX2 tumors. CEUS is more sensitive than CECT in detection of residual viable rabbit VX2 tumor after HIFU.</p>


Subject(s)
Animals , Female , Male , Rabbits , High-Intensity Focused Ultrasound Ablation , Liver Neoplasms, Experimental , Therapeutics , Microbubbles , Neoplasm, Residual , Diagnostic Imaging , Pathology , Phospholipids , Sulfur Hexafluoride , Tomography, Spiral Computed , Ultrasonography
18.
Acta Pharmaceutica Sinica ; (12): 261-268, 2013.
Article in Chinese | WPRIM | ID: wpr-235674

ABSTRACT

5-Flucytosine (5-FC) could be changed to 5-fluorouracil (5-FU) by cytosine deaminase (CD), the latter is able to kill cancer cells. However, there is no efficient method to deliver the CD gene into the tumor cells, which hampers the application of the suicide gene system. In this experiment, for the first time, the NDV has been utilized as a vector to deliver the CD gene into the cancer cells, the virus can infect the cancer cells specifically, replicate and assemble, while the cytosine deaminase is expressed. Then the CD converts the prodrug 5-FC into 5-FU to achieve the purpose of inhibiting tumor. Firstly, the whole genome of E. coli JM109 was extracted, and the CD gene was obtained by cloning method. Then the CD and IRES-EGFP were ligated into the pEE12.4 expression vector to become a recombinant pEE12.4IE-CD eukaryotic expression plasmid. The human liver cancer cells were transfected with the plasmid. The cells were treated with different concentrations of 5-FC, MTT method was used to determine the killing effect of CD/5-FC system on the human liver cancer cells. The cell deaths were 18.07%, 42.98% and 62.20% respectively when the concentrations of prodrug were at 10, 20 and 30 mmol x L(-1). In 5-FC acute toxicity experiment, Kunming mice were injected with different concentrations of 5-FC at intervals of 1:0.5. The LD50 of 5-FC through iv injection was determined by improved Karber's method, the LD50 was 507 mg x kg(-1) and the 95% confidence limit was 374-695 mg x kg(-1). According to the maximum LD0 dose of the LD50, the maximum safe dose was 200 mg x kg(-1). Body weight and clinic symptoms of the experimental animals were observed. These results laid the foundation to verify the antitumor effect and safety of CD/5-FC system in animal models. The CD gene was ligated into the NDV (rClone30) carrier, then the tumor-bearing animal was established to perform the tumor inhibiting experiment. The result showed that the recombinant rClone30-CD/5-FC system has a high antitumor activity in vivo. To summarize, CD gene has been cloned and its bioactivity has been confirmed in the mammalian cells. It is the first time in this study to utilize the recombinant NDV to deliver the CD gene into the tumor cells; our result proves the rClone30-CD/5-FC system is a potential method for cancer therapy.


Subject(s)
Animals , Chick Embryo , Humans , Mice , Antimetabolites, Antineoplastic , Metabolism , Pharmacology , Cell Death , Cytosine Deaminase , Genetics , Metabolism , Escherichia coli , Genetics , Metabolism , Flucytosine , Metabolism , Pharmacology , Fluorouracil , Metabolism , Pharmacology , Genetic Vectors , Hep G2 Cells , Lethal Dose 50 , Liver Neoplasms, Experimental , Pathology , Newcastle disease virus , Genetics , Plasmids , Recombinant Proteins , Genetics , Metabolism , Transfection , Tumor Burden
19.
Chinese Journal of Oncology ; (12): 337-340, 2013.
Article in Chinese | WPRIM | ID: wpr-284180

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the effect of enoyl coenzyme A hydratase-1 (Ech1) on the proliferation and invasion ability of mouse hepatocarcinoma Hca-P cells in vitro.</p><p><b>METHODS</b>Recombinant pcDNA3.1(+)-Ech1 gene and pcDNA3.1(+) were transfected into Hca-P cells by cationic liposomes introduction. Clone of PEch1 cells that stably expressing Ech1 and clone of control Pvector cells were screened by G418. The Ech1 expression was identified subsequently by reverse transcriptase-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA), respectively. The malignant behaviors of the cell lines were compared by proliferation, invasion and migration test.</p><p><b>RESULTS</b>The cell line Hca-P cells stably expressing Ech1 gene was constructed. The relative expression of Ech1 mRNA in the PEch1 group was 3.21 ± 0.43 and in the Pvector group was 1.44 ± 0.03, with a significant difference between the two groups (P = 0.029). The results of ELISA revealed that the expression of Ech1 protein was 0.140 ± 0.005 in the PEch1 group, 0.088 ± 0.003 in the Pvector group, and 0.078 ± 0.006 in the Hca-P group, showing a significant difference between the PEch1 group and the Pvector and Hca-P groups (P < 0.05). Transwell migration test showed that the number of penetrated cells in the PEch1 group was 143.00 ± 7.25 cells, significantly higher than that of the Pvector group (95.73 ± 3.88 cells) and un-treated Hca-1 group (106.67 ± 3.54 cells, both P < 0.05). The Transwell invasion assay showed that the number of penetrated cells was 77.20 ± 5.46 cells in the PEch1 group, significantly higher than 46.34 ± 4.35 cells in the Pvector group and 49.80 ± 5.21 cells in the un-treated Hca-1 group (both P < 0.05).</p><p><b>CONCLUSIONS</b>The results showed that overexpressed Ech1 in Hca-P cells may significantly increase the cell proliferation in a time-dependent manner. The up-regulation of Ech1 may increase to some extent the migration and invasion capacity of Hca-P cells. The efforts aiming at up-regulation of Ech1 expression may become a therapeutic target in the treatment of hepatocarcinoma.</p>


Subject(s)
Animals , Mice , Carbon-Carbon Double Bond Isomerases , Genetics , Metabolism , Cell Movement , Cell Proliferation , Liver Neoplasms, Experimental , Pathology , Neoplasm Invasiveness , Plasmids , RNA, Messenger , Metabolism , Recombinant Proteins , Genetics , Metabolism , Transfection , Tumor Cells, Cultured , Up-Regulation
20.
Chinese Journal of Oncology ; (12): 892-896, 2013.
Article in Chinese | WPRIM | ID: wpr-329021

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the efficacy of treatment with siRNA targeting Bcl-2 in combination with HCPT against H₂₂ hepatoma transplanted in mice.</p><p><b>METHODS</b>siRNA targeting Bcl-2 mRNA was successfully designed and synthesized. Then, the Bcl-2 siRNA was transfected into H₂₂ hepatoma transplanted in mice in combination with HCPT for treatment. The changes of tumor volume, body weight and survival rate were observed. Tumor tissues were processed into paraffin blocks and sections were stained with hematoxylin and eosin (HE) to investigate the morphological changes of the tumor cells. RT-polymerase chain reaction (PT-PCR) was used to assess the expression of Bcl-2 mRNA in tumors and cells. Cell cycle and apoptosis of H₂₂ hepatoma cells transplanted in mice were further determined by flow cytometry.</p><p><b>RESULTS</b>After treatment for 21 days, the tumor volume was around (571.47 ± 67.31)mm³ in the group of siRNA in combination with HCPT, which was significant smaller than that of the groups of HCPT [(880.47 ± 107.31) mm³, P < 0.05], siRNA interfere [(1119.55 ± 158.60)mm³, P < 0.01] and saline (1357.64 ± 197.92)mm³, P < 0.01]. The median survival time of the group receiving siRNA in combination with HCPT treatment was 26 days, which was significantly longer than that of the group receiving HCPT (14 day, P < 0.05), siRNA interfere (21 day, P < 0.05) and saline (12 day, P < 0.05). Larger necrotic area, lower expression of Bcl-2 mRNA, less cells at S phase and more apoptotic cells could be obviously seen in tumor tissues in the group of siRNA in combination with HCPT treatment.</p><p><b>CONCLUSION</b>Bcl-2 siRNA in combination with HCPT has good synergetic antitumor efficacy in H₂₂ hepatoma-bearing mice.</p>


Subject(s)
Animals , Male , Mice , Antineoplastic Agents, Phytogenic , Pharmacology , Apoptosis , Camptothecin , Pharmacology , Cell Cycle , Drug Synergism , Liver Neoplasms, Experimental , Metabolism , Pathology , Mice, Inbred BALB C , Proto-Oncogene Proteins c-bcl-2 , Genetics , Metabolism , RNA, Messenger , Metabolism , RNA, Small Interfering , Genetics , Random Allocation , Transfection , Tumor Burden
SELECTION OF CITATIONS
SEARCH DETAIL